Quincy Bioscience tells jurors it relied on FTC guidance in supporting claims for Prevagen
In a 7-year-old case that focused on the science behind Prevagen, jurors were introduced to the concept of “competent and reliable scientific evidence.” But Federal Trade Commission guidance only proved to be an important consideration for Quincy, not the state of New York.
Source: naturalproductsinsider.com